Efficacy of Patient Management for Lymphoma Diagnosed at Nimes University Hospital From 1999 to 2018. DVR-Lym-Nim
NCT04947618 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2024-01-24
Summary
Observation of a cohort of 400 patients with different types of lymphomas.
Conditions
- Lymphoma, Malignant
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Nīmes
lead OTHER
Principal Investigators
-
Anissa MEGZARI · CHU de Nîmes (Nîmes University Hospital)
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-22
- Primary Completion
- 2026-01-31
- Completion
- 2026-01-31
Countries
- France
Study Locations
More Related Trials
-
EBV-associated Diffuse Large B Cell Lymphoma
NCT03378947 ·Status: COMPLETED
-
Transplantation After Complete Response In Patients With T-cell Lymphoma
NCT05444712 ·Status: RECRUITING ·Phase: NA
-
Signal Detection in Monoclonal and New Agents in Lymphoma
NCT02849912 ·Status: COMPLETED
-
Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma
NCT04113226 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment
NCT01007292 ·Status: COMPLETED ·Phase: PHASE2
-
ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma
NCT00144807 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of the Quality of Life of Patients With Lymphomas Treated With Oral Therapy
NCT04985214 ·Status: UNKNOWN
-
Living Conditions of Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma in the Côte d'Or Region
NCT04859920 ·Status: COMPLETED
-
Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma
NCT01939327 ·Status: COMPLETED ·Phase: PHASE2
-
Lenalidomide and R-CHOP in B-cell Lymphoma
NCT00901615 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab
NCT00561379 ·Status: COMPLETED ·Phase: NA
-
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
NCT05700149 ·Status: RECRUITING
-
IMPACT Non Hodgkins Lymphoma (NHL) Study
NCT00903812 ·Status: COMPLETED
-
Ibrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged ≤65 Years
NCT05429918 ·Status: UNKNOWN
-
Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?
NCT03681938 ·Status: UNKNOWN
-
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
NCT05524298 ·Status: RECRUITING
-
Radiomics and Metabolomics in the Follow-up of CAR T-cells for Refractory or Relapsed Non-Hodgkin's Lymphoma
NCT05422521 ·Status: RECRUITING ·Phase: NA
-
Interest of Individual Biomarkers From the Identification of Tumor Genotype by High-throughput Molecular Techniques
NCT04417803 ·Status: RECRUITING ·Phase: NA
-
The Response Study of Yt90-Zevalin in Patients With Diffuse Large B-cell Lymphoma After 6 Cycles of CHOP
NCT00440583 ·Status: COMPLETED ·Phase: PHASE2
-
R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma
NCT00137995 ·Status: COMPLETED ·Phase: PHASE3
-
Mantel Cell Lymphoma Efficacy of Rituximab Maintenance
NCT00921414 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma
NCT02474550 ·Status: UNKNOWN
-
Mediastinal Grey Zone Lymphoma From the LYSA
NCT03037177 ·Status: COMPLETED
-
Study of Prognostic Factors in Adult Lymphoblastic Lymphoma
NCT03571997 ·Status: UNKNOWN
-
Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)
NCT06781437 ·Status: RECRUITING